What are the effects of implementing patient-controlled admissions in inpatient care? A study protocol of a large-scale implementation and naturalistic evaluation for adult and adolescent patients with severe psychiatric conditions throughout Region Stockholm.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 08 2022
Historique:
entrez: 16 8 2022
pubmed: 17 8 2022
medline: 19 8 2022
Statut: epublish

Résumé

Patient-controlled admissions (PCAs) represent a change in psychiatric inpatient care where patients are allowed to decide for themselves when hospitalisation might be required. Prior research has demonstrated that PCA increase the number of admissions, but decrease days in inpatient care, while both the admissions to and days in involuntary care decrease. However, investigations have been restricted to specific patient groups and have not examined other possible benefits, such as effects on symptoms, quality of life and autonomy. This study explores the implementation process and effects of PCA in Region Stockholm, who is currently introducing PCA for all patients with severe psychiatric conditions and extensive healthcare utilisation. In total, the study comprises approximately 45 inpatient wards, including child and adolescent psychiatry. In a naturalistic evaluation, patients assigned PCA will be followed up to 36 months, both with regard to hospitalisation rates and self-reported outcomes. In addition, qualitative studies will explore the experiences of patients, caregivers of adolescents and healthcare providers. Approval has been granted by the Swedish Ethical Review Authority (Dnr: 2020-06498). The findings from this study will be disseminated via publications in international peer-reviewed journals, at scientific conferences, as part of two doctoral theses, and through the Swedish Partnership for Mental Health. NCT04862897.

Identifiants

pubmed: 35973700
pii: bmjopen-2022-065770
doi: 10.1136/bmjopen-2022-065770
pmc: PMC9386218
doi:

Banques de données

ClinicalTrials.gov
['NCT04862897']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e065770

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Expert Rev Pharmacoecon Outcomes Res. 2005 Jun;5(3):353-64
pubmed: 19807604
Behav Res Ther. 2000 Aug;38(8):835-55
pubmed: 10937431
Int J Ment Health Nurs. 2020 Oct;29(5):962-971
pubmed: 32406168
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
Patient Educ Couns. 2017 Jun;100(6):1144-1152
pubmed: 28096034
BMC Health Serv Res. 2016 Sep 22;16(1):513
pubmed: 27659102
BMC Med Ethics. 2013 Dec 06;14:49
pubmed: 24314345
Perspect Psychiatr Care. 2010 Apr;46(2):127-34
pubmed: 20377800
Int J Eat Disord. 2020 Oct;53(10):1685-1695
pubmed: 32666605
Acta Psychiatr Scand. 2018 Apr;137(4):355-363
pubmed: 29504127
JAMA Netw Open. 2019 Jun 5;2(6):e195463
pubmed: 31173128
Nord J Psychiatry. 2017 Jul;71(5):362-369
pubmed: 28318346
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Nord J Psychiatry. 2015;69(8):574-86
pubmed: 25832757
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
J Psychiatr Res. 2021 Dec;144:331-337
pubmed: 34737122
BMC Health Serv Res. 2021 Jun 24;21(1):598
pubmed: 34162390
Cogn Behav Ther. 2016 Apr;45(3):182-95
pubmed: 26886248
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Qual Life Res. 2014 Mar;23(2):431-42
pubmed: 23975375
Nord J Psychiatry. 2017 Jul;71(5):370-377
pubmed: 28326863
Int J Ment Health Syst. 2016 Feb 25;10:11
pubmed: 26918028
Int J Ment Health Nurs. 2008 Dec;17(6):439-49
pubmed: 19128291

Auteurs

Maria Smitmanis Lyle (M)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Emelie Allenius (E)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Sigrid Salomonsson (S)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Anna Björkdahl (A)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Mattias Strand (M)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Lena Flyckt (L)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Clara Hellner (C)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Tobias Lundgren (T)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Nitya Jayaram-Lindström (N)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.

Alexander Rozental (A)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden alexander.rozental@ki.se.
Stockholm County Council, Stockholm Health Care Services, Stockholm, Sweden.
Department of Psychology, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH